Your hair can feel like a small thing until cancer treatment threatens to take it away. We sit down with board-certified hematologist-oncologist Dr. Tiffany Pompa to talk honestly about chemotherapy hair loss, why it happens, and why the emotional impact is often underestimated by everyone except the people living it. We also dig into how immunotherapy differs, why hair loss is usually uncommon with many immunotherapy regimens in real practice, and where the published numbers can be confusing without context.
From there, we get practical about scalp cooling and cold cap therapy: who benefits most, when to start, and what to expect on infusion days. Dr. Pompa explains why taxane chemotherapy such as paclitaxel and docetaxel is a common setting for scalp cooling, especially in breast cancer, gynecologic cancers like ovarian cancer, and lung cancer. We walk through the three FDA-approved systems DigniCap, Paxman, and AMA, including the real-life routine of wearing the cap before, during, and after treatment, plus the most common side effects like headaches, intense cold, and rare frostbite.
Access matters as much as science, so we talk insurance coverage, cost, and advocacy. Dr. Pompa shares how she argues medical necessity, why NCCN guidelines help, what Medicare and Medicaid approval in 2026 changes, and how state legislation can expand coverage. We also discuss manual frozen gel cap options like Penguin caps for patients who need a more affordable workaround, along with the tradeoffs. If you or someone you love is starting chemo, this conversation gives you language, options, and a clear next step: ask early. Subscribe, share this with someone who needs it, and leave a review so more patients and clinicians learn that hair loss prevention is part of quality cancer care.